| Response to treatment | Total | OV Group | Placebo Group |
| Complete response | 50 (80.6) | 26 (86.7) | 24 (75.0) |
| Partial response | 6 (9.7) | 1 (3.3) | 5 (15.6) |
| Disease persistence | 2 (3.2) | 1 (3.3) | 1 (3.1) |
| Disease progression | 4 (6.5) | 2 (6.7) | 2 (6.3) |
| Total | 62 | 30 | 32 |